Target intelligence / Profile preview

Thermal ablation

Molecular classification
Not applicable (Medical procedure)
01

Overview

Thermal ablation is a minimally invasive medical procedure used to destroy diseased or unwanted tissue, most commonly tumors, through the application of extreme temperatures. It is not a biological molecule or receptor but a physical intervention that utilizes energy sources—such as radiofrequency, microwave, or laser—to induce rapid protein denaturation and coagulative necrosis within a targeted volume (National Cancer Institute, 2023). This technique is widely employed in oncology for treating primary and metastatic tumors in the liver, lung, kidney, and bone, as well as in cardiology for treating arrhythmias (StatPearls, 2023). Unlike pharmacological agents, thermal ablation provides immediate physical destruction of the target area without relying on specific biochemical pathways. While highly effective for localized control, its efficacy can be limited by the heat sink effect near large blood vessels, which can dissipate heat and lead to incomplete treatment (Mayo Clinic, 2024). There is also a risk of collateral damage to adjacent vital structures, requiring precise image guidance during the procedure. In recent years, it has been increasingly studied in combination with immunotherapies to enhance systemic anti-tumor immune responses by releasing tumor-associated antigens into the bloodstream (Journal of Clinical Oncology, 2022). This synergy aims to convert a cold tumor environment into an immunologically hot one, potentially improving the outcomes of checkpoint inhibitor therapy.

Other names
Radiofrequency ablationMicrowave ablationLaser interstitial thermal therapyHigh-intensity focused ultrasoundCryoablationThermal therapy
02

Mechanism of action

Induction of localized tissue destruction via extreme temperature-mediated coagulative necrosis and protein denaturation.

03

Biological functions

Cell deathCoagulative necrosisProtein denaturationTissue destruction
04

Disease associations

CancerCardiac arrhythmiaVaricose veinsBenign prostatic hyperplasiaEndometrial hyperplasia
05

Safety considerations

Off-target thermal damage to adjacent organsHemorrhageInfectionHeat sink effect (blood flow dissipating thermal energy)Post-ablation syndrome
06

Biomarkers

Radiological imaging (CT/MRI/Ultrasound) for necrosis zoneSerum tumor markers (e.g., AFP, CEA, PSA) for treatment response

Beyond the preview

Go deeper on Thermal ablation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thermal ablation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call